nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Glyburide—CPT1A—breast cancer	0.00611	0.279	CrCbGaD
Tolazamide—KCNJ11—mammary gland—breast cancer	0.00557	0.189	CbGeAlD
Tolazamide—ABCC8—mammary gland—breast cancer	0.00513	0.175	CbGeAlD
Tolazamide—Gliclazide—VEGFA—breast cancer	0.0044	0.201	CrCbGaD
Tolazamide—KCNJ1—Neuronal System—KCNH1—breast cancer	0.00283	0.0153	CbGpPWpGaD
Tolazamide—Glyburide—ABCC1—breast cancer	0.0027	0.124	CrCbGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.00265	0.0143	CbGpPWpGaD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.00257	0.0139	CbGpPWpGaD
Tolazamide—ABCC8—endometrium—breast cancer	0.00256	0.0872	CbGeAlD
Tolazamide—ABCC8—pituitary gland—breast cancer	0.00232	0.0789	CbGeAlD
Tolazamide—KCNJ11—female reproductive system—breast cancer	0.0023	0.0784	CbGeAlD
Tolazamide—KCNJ11—adrenal gland—breast cancer	0.00225	0.0765	CbGeAlD
Tolazamide—ABCC8—Neuronal System—KCNN4—breast cancer	0.00225	0.0121	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—KCNN4—breast cancer	0.00218	0.0118	CbGpPWpGaD
Tolazamide—ABCC8—ABC-family proteins mediated transport—ABCB1—breast cancer	0.00218	0.0117	CbGpPWpGaD
Tolazamide—KCNJ11—female gonad—breast cancer	0.0021	0.0713	CbGeAlD
Tolazamide—ABCC8—adrenal gland—breast cancer	0.00207	0.0705	CbGeAlD
Tolazamide—KCNJ11—endocrine gland—breast cancer	0.00195	0.0663	CbGeAlD
Tolazamide—ABCC8—Regulation of insulin secretion—SLC2A2—breast cancer	0.00194	0.0105	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—SLC2A2—breast cancer	0.00188	0.0101	CbGpPWpGaD
Tolazamide—Chlorpropamide—PTGS1—breast cancer	0.00181	0.0825	CrCbGaD
Tolazamide—ABCC8—endocrine gland—breast cancer	0.0018	0.0611	CbGeAlD
Tolazamide—KCNJ11—Type II diabetes mellitus—MTOR—breast cancer	0.00173	0.00933	CbGpPWpGaD
Tolazamide—ABCC8—Integration of energy metabolism—SLC2A2—breast cancer	0.00152	0.00822	CbGpPWpGaD
Tolazamide—ABCC8—Regulation of insulin secretion—SLC2A1—breast cancer	0.0015	0.0081	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—SLC2A2—breast cancer	0.00148	0.00797	CbGpPWpGaD
Tolazamide—KCNJ11—Type II diabetes mellitus—MAPK8—breast cancer	0.00146	0.00789	CbGpPWpGaD
Tolazamide—Glipizide—CYP3A4—breast cancer	0.00146	0.0667	CrCbGaD
Tolazamide—Discomfort—Vinorelbine—breast cancer	0.00146	0.00191	CcSEcCtD
Tolazamide—KCNJ11—Regulation of insulin secretion—SLC2A1—breast cancer	0.00146	0.00785	CbGpPWpGaD
Tolazamide—Dyspepsia—Tamoxifen—breast cancer	0.00146	0.00191	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—KCNH1—breast cancer	0.00145	0.00781	CbGpPWpGaD
Tolazamide—Rash—Idarubicin—breast cancer	0.00145	0.00189	CcSEcCtD
Tolazamide—Rash—Raloxifene—breast cancer	0.00145	0.00189	CcSEcCtD
Tolazamide—Headache—Idarubicin—breast cancer	0.00144	0.00188	CcSEcCtD
Tolazamide—Headache—Raloxifene—breast cancer	0.00144	0.00188	CcSEcCtD
Tolazamide—Nausea—Anastrozole—breast cancer	0.00143	0.00188	CcSEcCtD
Tolazamide—Nausea—Letrozole—breast cancer	0.00143	0.00188	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—breast cancer	0.00143	0.00187	CcSEcCtD
Tolazamide—Erythema—Mitoxantrone—breast cancer	0.00143	0.00187	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00143	0.00187	CcSEcCtD
Tolazamide—Glyburide—ABCG2—breast cancer	0.00143	0.0651	CrCbGaD
Tolazamide—Fatigue—Tamoxifen—breast cancer	0.00143	0.00187	CcSEcCtD
Tolazamide—Dyspepsia—Melphalan—breast cancer	0.00142	0.00187	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—KCNH1—breast cancer	0.0014	0.00758	CbGpPWpGaD
Tolazamide—Feeling abnormal—Vinblastine—breast cancer	0.0014	0.00184	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Melphalan—breast cancer	0.0014	0.00183	CcSEcCtD
Tolazamide—Fatigue—Melphalan—breast cancer	0.0014	0.00183	CcSEcCtD
Tolazamide—Erythema—Gemcitabine—breast cancer	0.00139	0.00182	CcSEcCtD
Tolazamide—Dyspepsia—Goserelin—breast cancer	0.00139	0.00182	CcSEcCtD
Tolazamide—Thrombocytopenia—Vinorelbine—breast cancer	0.00138	0.00181	CcSEcCtD
Tolazamide—Abdominal distension—Capecitabine—breast cancer	0.00138	0.00181	CcSEcCtD
Tolazamide—Erythema—Fluorouracil—breast cancer	0.00137	0.00179	CcSEcCtD
Tolazamide—Nausea—Idarubicin—breast cancer	0.00136	0.00178	CcSEcCtD
Tolazamide—Nausea—Raloxifene—breast cancer	0.00136	0.00178	CcSEcCtD
Tolazamide—Fatigue—Goserelin—breast cancer	0.00136	0.00178	CcSEcCtD
Tolazamide—KCNJ11—lymph node—breast cancer	0.00135	0.0459	CbGeAlD
Tolazamide—Pancytopenia—Docetaxel—breast cancer	0.00135	0.00176	CcSEcCtD
Tolazamide—Asthenia—Chlorambucil—breast cancer	0.00133	0.00175	CcSEcCtD
Tolazamide—Ill-defined disorder—Mitoxantrone—breast cancer	0.00133	0.00174	CcSEcCtD
Tolazamide—Ill-defined disorder—Irinotecan—breast cancer	0.00133	0.00174	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—breast cancer	0.00132	0.00173	CcSEcCtD
Tolazamide—Thrombocytopenia—Thiotepa—breast cancer	0.00132	0.00173	CcSEcCtD
Tolazamide—Pruritus—Chlorambucil—breast cancer	0.00131	0.00172	CcSEcCtD
Tolazamide—Urticaria—Tamoxifen—breast cancer	0.00131	0.00172	CcSEcCtD
Tolazamide—Pancytopenia—Capecitabine—breast cancer	0.0013	0.00171	CcSEcCtD
Tolazamide—Feeling abnormal—Goserelin—breast cancer	0.0013	0.0017	CcSEcCtD
Tolazamide—Ill-defined disorder—Gemcitabine—breast cancer	0.00129	0.00169	CcSEcCtD
Tolazamide—Malaise—Mitoxantrone—breast cancer	0.00129	0.00169	CcSEcCtD
Tolazamide—Malaise—Irinotecan—breast cancer	0.00129	0.00169	CcSEcCtD
Tolazamide—Urticaria—Melphalan—breast cancer	0.00129	0.00168	CcSEcCtD
Tolazamide—Vertigo—Irinotecan—breast cancer	0.00128	0.00168	CcSEcCtD
Tolazamide—Leukopenia—Irinotecan—breast cancer	0.00128	0.00168	CcSEcCtD
Tolazamide—Leukopenia—Mitoxantrone—breast cancer	0.00128	0.00168	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ACHE—breast cancer	0.00126	0.00681	CbGpPWpGaD
Tolazamide—Malaise—Gemcitabine—breast cancer	0.00126	0.00164	CcSEcCtD
Tolazamide—Urticaria—Goserelin—breast cancer	0.00125	0.00164	CcSEcCtD
Tolazamide—Photosensitivity reaction—Capecitabine—breast cancer	0.00125	0.00164	CcSEcCtD
Tolazamide—Leukopenia—Gemcitabine—breast cancer	0.00125	0.00163	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—FASN—breast cancer	0.00124	0.0067	CbGpPWpGaD
Tolazamide—ABCC8—Regulation of insulin secretion—ITPR1—breast cancer	0.00123	0.00665	CbGpPWpGaD
Tolazamide—Leukopenia—Fluorouracil—breast cancer	0.00123	0.0016	CcSEcCtD
Tolazamide—Asthenia—Vinblastine—breast cancer	0.00122	0.0016	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Vinorelbine—breast cancer	0.00122	0.0016	CcSEcCtD
Tolazamide—Fatigue—Vinorelbine—breast cancer	0.00122	0.0016	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—FASN—breast cancer	0.00121	0.0065	CbGpPWpGaD
Tolazamide—Discomfort—Mitoxantrone—breast cancer	0.0012	0.00157	CcSEcCtD
Tolazamide—Discomfort—Irinotecan—breast cancer	0.0012	0.00157	CcSEcCtD
Tolazamide—KCNJ11—Regulation of insulin secretion—ITPR1—breast cancer	0.00119	0.00644	CbGpPWpGaD
Tolazamide—Dyspepsia—Thiotepa—breast cancer	0.00119	0.00156	CcSEcCtD
Tolazamide—Asthenia—Tamoxifen—breast cancer	0.00119	0.00155	CcSEcCtD
Tolazamide—Gliclazide—ALB—breast cancer	0.00118	0.0541	CrCbGaD
Tolazamide—ABCC8—Integration of energy metabolism—SLC2A1—breast cancer	0.00118	0.00637	CbGpPWpGaD
Tolazamide—Agranulocytosis—Docetaxel—breast cancer	0.00118	0.00155	CcSEcCtD
Tolazamide—Discomfort—Gemcitabine—breast cancer	0.00117	0.00153	CcSEcCtD
Tolazamide—Pruritus—Tamoxifen—breast cancer	0.00117	0.00153	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Thiotepa—breast cancer	0.00117	0.00153	CcSEcCtD
Tolazamide—Erythema—Paclitaxel—breast cancer	0.00117	0.00153	CcSEcCtD
Tolazamide—Feeling abnormal—Vinorelbine—breast cancer	0.00117	0.00153	CcSEcCtD
Tolazamide—Fatigue—Thiotepa—breast cancer	0.00116	0.00153	CcSEcCtD
Tolazamide—Asthenia—Melphalan—breast cancer	0.00116	0.00152	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.00116	0.00626	CbGpPWpGaD
Tolazamide—KCNJ11—Type II diabetes mellitus—TNF—breast cancer	0.00116	0.00624	CbGpPWpGaD
Tolazamide—Discomfort—Fluorouracil—breast cancer	0.00115	0.00151	CcSEcCtD
Tolazamide—Pruritus—Melphalan—breast cancer	0.00115	0.0015	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—SLC2A1—breast cancer	0.00114	0.00617	CbGpPWpGaD
Tolazamide—Agranulocytosis—Capecitabine—breast cancer	0.00114	0.0015	CcSEcCtD
Tolazamide—Thrombocytopenia—Irinotecan—breast cancer	0.00114	0.0015	CcSEcCtD
Tolazamide—Thrombocytopenia—Mitoxantrone—breast cancer	0.00114	0.0015	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—breast cancer	0.00113	0.00149	CcSEcCtD
Tolazamide—Asthenia—Goserelin—breast cancer	0.00113	0.00148	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.00113	0.00607	CbGpPWpGaD
Tolazamide—Dizziness—Vinblastine—breast cancer	0.00113	0.00147	CcSEcCtD
Tolazamide—Urticaria—Vinorelbine—breast cancer	0.00112	0.00147	CcSEcCtD
Tolazamide—Pruritus—Goserelin—breast cancer	0.00112	0.00146	CcSEcCtD
Tolazamide—Feeling abnormal—Thiotepa—breast cancer	0.00111	0.00146	CcSEcCtD
Tolazamide—Thrombocytopenia—Gemcitabine—breast cancer	0.00111	0.00146	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—breast cancer	0.00111	0.00146	CcSEcCtD
Tolazamide—Nausea—Chlorambucil—breast cancer	0.0011	0.00144	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—BCHE—breast cancer	0.0011	0.00593	CbGpPWpGaD
Tolazamide—Thrombocytopenia—Fluorouracil—breast cancer	0.00109	0.00143	CcSEcCtD
Tolazamide—Dizziness—Tamoxifen—breast cancer	0.00109	0.00143	CcSEcCtD
Tolazamide—Ill-defined disorder—Paclitaxel—breast cancer	0.00108	0.00142	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00108	0.00581	CbGpPWpGaD
Tolazamide—Urticaria—Thiotepa—breast cancer	0.00107	0.00141	CcSEcCtD
Tolazamide—Headache—Vinblastine—breast cancer	0.00107	0.0014	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—STK11—breast cancer	0.00106	0.00574	CbGpPWpGaD
Tolazamide—Malaise—Paclitaxel—breast cancer	0.00105	0.00138	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—breast cancer	0.00105	0.00137	CcSEcCtD
Tolazamide—Vertigo—Paclitaxel—breast cancer	0.00105	0.00137	CcSEcCtD
Tolazamide—Dizziness—Goserelin—breast cancer	0.00104	0.00137	CcSEcCtD
Tolazamide—Leukopenia—Paclitaxel—breast cancer	0.00104	0.00137	CcSEcCtD
Tolazamide—Rash—Tamoxifen—breast cancer	0.00104	0.00137	CcSEcCtD
Tolazamide—Headache—Tamoxifen—breast cancer	0.00104	0.00136	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—STK11—breast cancer	0.00103	0.00557	CbGpPWpGaD
Tolazamide—Hyponatraemia—Doxorubicin—breast cancer	0.00103	0.00135	CcSEcCtD
Tolazamide—Dyspepsia—Mitoxantrone—breast cancer	0.00103	0.00134	CcSEcCtD
Tolazamide—Dyspepsia—Irinotecan—breast cancer	0.00103	0.00134	CcSEcCtD
Tolazamide—Rash—Melphalan—breast cancer	0.00102	0.00134	CcSEcCtD
Tolazamide—Asthenia—Vinorelbine—breast cancer	0.00101	0.00133	CcSEcCtD
Tolazamide—Nausea—Vinblastine—breast cancer	0.00101	0.00132	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Irinotecan—breast cancer	0.00101	0.00132	CcSEcCtD
Tolazamide—Fatigue—Irinotecan—breast cancer	0.00101	0.00132	CcSEcCtD
Tolazamide—Fatigue—Mitoxantrone—breast cancer	0.00101	0.00132	CcSEcCtD
Tolazamide—Pruritus—Vinorelbine—breast cancer	0.001	0.00131	CcSEcCtD
Tolazamide—Rash—Goserelin—breast cancer	0.000995	0.0013	CcSEcCtD
Tolazamide—Headache—Goserelin—breast cancer	0.000989	0.0013	CcSEcCtD
Tolazamide—Erythema—Docetaxel—breast cancer	0.000988	0.00129	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000985	0.00531	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000985	0.00531	CbGpPWpGaD
Tolazamide—Dyspepsia—Fluorouracil—breast cancer	0.000983	0.00129	CcSEcCtD
Tolazamide—Nausea—Tamoxifen—breast cancer	0.000982	0.00129	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000981	0.00128	CcSEcCtD
Tolazamide—Discomfort—Paclitaxel—breast cancer	0.00098	0.00128	CcSEcCtD
Tolazamide—Fatigue—Gemcitabine—breast cancer	0.000979	0.00128	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—breast cancer	0.00097	0.00127	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—ITPR1—breast cancer	0.000969	0.00523	CbGpPWpGaD
Tolazamide—Asthenia—Thiotepa—breast cancer	0.000969	0.00127	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000964	0.00126	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—breast cancer	0.000963	0.00126	CcSEcCtD
Tolazamide—Nausea—Melphalan—breast cancer	0.000961	0.00126	CcSEcCtD
Tolazamide—Feeling abnormal—Irinotecan—breast cancer	0.000961	0.00126	CcSEcCtD
Tolazamide—Feeling abnormal—Mitoxantrone—breast cancer	0.000961	0.00126	CcSEcCtD
Tolazamide—Erythema—Capecitabine—breast cancer	0.000956	0.00125	CcSEcCtD
Tolazamide—Pruritus—Thiotepa—breast cancer	0.000955	0.00125	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—ITPR1—breast cancer	0.00094	0.00507	CbGpPWpGaD
Tolazamide—Nausea—Goserelin—breast cancer	0.000938	0.00123	CcSEcCtD
Tolazamide—Feeling abnormal—Gemcitabine—breast cancer	0.000936	0.00123	CcSEcCtD
Tolazamide—Dizziness—Vinorelbine—breast cancer	0.000935	0.00123	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—breast cancer	0.000933	0.00122	CcSEcCtD
Tolazamide—Thrombocytopenia—Paclitaxel—breast cancer	0.000931	0.00122	CcSEcCtD
Tolazamide—Urticaria—Mitoxantrone—breast cancer	0.000926	0.00121	CcSEcCtD
Tolazamide—Feeling abnormal—Fluorouracil—breast cancer	0.00092	0.00121	CcSEcCtD
Tolazamide—Pancytopenia—Epirubicin—breast cancer	0.000908	0.00119	CcSEcCtD
Tolazamide—Dizziness—Thiotepa—breast cancer	0.000893	0.00117	CcSEcCtD
Tolazamide—Rash—Vinorelbine—breast cancer	0.000892	0.00117	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—breast cancer	0.000891	0.00117	CcSEcCtD
Tolazamide—Ill-defined disorder—Capecitabine—breast cancer	0.000887	0.00116	CcSEcCtD
Tolazamide—Urticaria—Fluorouracil—breast cancer	0.000887	0.00116	CcSEcCtD
Tolazamide—Headache—Vinorelbine—breast cancer	0.000886	0.00116	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—breast cancer	0.000884	0.00116	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—COMT—breast cancer	0.000879	0.00474	CbGpPWpGaD
Tolazamide—Chlorpropamide—ABCB1—breast cancer	0.000879	0.0401	CrCbGaD
Tolazamide—Photosensitivity reaction—Epirubicin—breast cancer	0.000873	0.00114	CcSEcCtD
Tolazamide—Malaise—Capecitabine—breast cancer	0.000862	0.00113	CcSEcCtD
Tolazamide—Vertigo—Capecitabine—breast cancer	0.000859	0.00113	CcSEcCtD
Tolazamide—Leukopenia—Capecitabine—breast cancer	0.000856	0.00112	CcSEcCtD
Tolazamide—Rash—Thiotepa—breast cancer	0.000851	0.00112	CcSEcCtD
Tolazamide—Agranulocytosis—Methotrexate—breast cancer	0.00085	0.00111	CcSEcCtD
Tolazamide—Headache—Thiotepa—breast cancer	0.000846	0.00111	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—breast cancer	0.00084	0.0011	CcSEcCtD
Tolazamide—Nausea—Vinorelbine—breast cancer	0.00084	0.0011	CcSEcCtD
Tolazamide—Dyspepsia—Paclitaxel—breast cancer	0.000837	0.0011	CcSEcCtD
Tolazamide—Asthenia—Mitoxantrone—breast cancer	0.000837	0.0011	CcSEcCtD
Tolazamide—Asthenia—Irinotecan—breast cancer	0.000837	0.0011	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000821	0.00108	CcSEcCtD
Tolazamide—Fatigue—Paclitaxel—breast cancer	0.00082	0.00107	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000816	0.0044	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—COX11—breast cancer	0.000816	0.0044	CbGpPWpGaD
Tolazamide—Asthenia—Gemcitabine—breast cancer	0.000815	0.00107	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—breast cancer	0.000808	0.00106	CcSEcCtD
Tolazamide—Discomfort—Capecitabine—breast cancer	0.000804	0.00105	CcSEcCtD
Tolazamide—Pruritus—Gemcitabine—breast cancer	0.000804	0.00105	CcSEcCtD
Tolazamide—Nausea—Thiotepa—breast cancer	0.000802	0.00105	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—breast cancer	0.000796	0.00104	CcSEcCtD
Tolazamide—Pruritus—Fluorouracil—breast cancer	0.00079	0.00104	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—breast cancer	0.000789	0.00103	CcSEcCtD
Tolazamide—Feeling abnormal—Paclitaxel—breast cancer	0.000784	0.00103	CcSEcCtD
Tolazamide—Dizziness—Irinotecan—breast cancer	0.000771	0.00101	CcSEcCtD
Tolazamide—Thrombocytopenia—Capecitabine—breast cancer	0.000764	0.001	CcSEcCtD
Tolazamide—Urticaria—Paclitaxel—breast cancer	0.000756	0.00099	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000747	0.00403	CbGpPWpGaD
Tolazamide—Dizziness—Fluorouracil—breast cancer	0.000739	0.000968	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—breast cancer	0.000736	0.000964	CcSEcCtD
Tolazamide—Rash—Irinotecan—breast cancer	0.000735	0.000963	CcSEcCtD
Tolazamide—Rash—Mitoxantrone—breast cancer	0.000735	0.000963	CcSEcCtD
Tolazamide—Headache—Mitoxantrone—breast cancer	0.000731	0.000957	CcSEcCtD
Tolazamide—Headache—Irinotecan—breast cancer	0.000731	0.000957	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000719	0.00388	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000719	0.00388	CbGpPWpGaD
Tolazamide—Rash—Gemcitabine—breast cancer	0.000716	0.000938	CcSEcCtD
Tolazamide—Glyburide—CYP3A4—breast cancer	0.000713	0.0325	CrCbGaD
Tolazamide—Erythema—Methotrexate—breast cancer	0.000712	0.000933	CcSEcCtD
Tolazamide—Headache—Gemcitabine—breast cancer	0.000712	0.000932	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—breast cancer	0.00071	0.00093	CcSEcCtD
Tolazamide—Rash—Fluorouracil—breast cancer	0.000704	0.000923	CcSEcCtD
Tolazamide—Headache—Fluorouracil—breast cancer	0.0007	0.000917	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Docetaxel—breast cancer	0.000696	0.000912	CcSEcCtD
Tolazamide—Fatigue—Docetaxel—breast cancer	0.000695	0.000911	CcSEcCtD
Tolazamide—Nausea—Mitoxantrone—breast cancer	0.000693	0.000907	CcSEcCtD
Tolazamide—Nausea—Irinotecan—breast cancer	0.000693	0.000907	CcSEcCtD
Tolazamide—Dyspepsia—Capecitabine—breast cancer	0.000687	0.0009	CcSEcCtD
Tolazamide—Asthenia—Paclitaxel—breast cancer	0.000682	0.000894	CcSEcCtD
Tolazamide—Nausea—Gemcitabine—breast cancer	0.000675	0.000884	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Capecitabine—breast cancer	0.000674	0.000883	CcSEcCtD
Tolazamide—Fatigue—Capecitabine—breast cancer	0.000673	0.000882	CcSEcCtD
Tolazamide—Pruritus—Paclitaxel—breast cancer	0.000673	0.000882	CcSEcCtD
Tolazamide—Erythema—Epirubicin—breast cancer	0.000666	0.000873	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—breast cancer	0.000664	0.00087	CcSEcCtD
Tolazamide—Nausea—Fluorouracil—breast cancer	0.000663	0.000869	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—breast cancer	0.000661	0.000865	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—ACHE—breast cancer	0.000645	0.00348	CbGpPWpGaD
Tolazamide—Feeling abnormal—Capecitabine—breast cancer	0.000643	0.000843	CcSEcCtD
Tolazamide—Malaise—Methotrexate—breast cancer	0.000642	0.000841	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—breast cancer	0.00064	0.000838	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—breast cancer	0.000637	0.000835	CcSEcCtD
Tolazamide—Dizziness—Paclitaxel—breast cancer	0.000629	0.000824	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ACHE—breast cancer	0.000626	0.00337	CbGpPWpGaD
Tolazamide—Glyburide—ALB—breast cancer	0.000622	0.0284	CrCbGaD
Tolazamide—Urticaria—Capecitabine—breast cancer	0.00062	0.000812	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000619	0.00334	CbGpPWpGaD
Tolazamide—Ill-defined disorder—Epirubicin—breast cancer	0.000618	0.00081	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—breast cancer	0.000616	0.000808	CcSEcCtD
Tolazamide—Malaise—Epirubicin—breast cancer	0.000601	0.000787	CcSEcCtD
Tolazamide—Rash—Paclitaxel—breast cancer	0.0006	0.000786	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—breast cancer	0.000599	0.000785	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—breast cancer	0.000599	0.000784	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—breast cancer	0.000596	0.000781	CcSEcCtD
Tolazamide—Headache—Paclitaxel—breast cancer	0.000596	0.000781	CcSEcCtD
Tolazamide—Glyburide—ABCB1—breast cancer	0.000593	0.0271	CrCbGaD
Tolazamide—Asthenia—Docetaxel—breast cancer	0.000578	0.000758	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—breast cancer	0.000572	0.000749	CcSEcCtD
Tolazamide—Pruritus—Docetaxel—breast cancer	0.00057	0.000747	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—breast cancer	0.000569	0.000745	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000566	0.00305	CbGpPWpGaD
Tolazamide—Nausea—Paclitaxel—breast cancer	0.000565	0.00074	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—BCHE—breast cancer	0.000562	0.00303	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—BRAF—breast cancer	0.000561	0.00303	CbGpPWpGaD
Tolazamide—Discomfort—Epirubicin—breast cancer	0.00056	0.000734	CcSEcCtD
Tolazamide—Asthenia—Capecitabine—breast cancer	0.00056	0.000734	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—breast cancer	0.000556	0.000728	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—breast cancer	0.000554	0.000726	CcSEcCtD
Tolazamide—Pruritus—Capecitabine—breast cancer	0.000552	0.000723	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—breast cancer	0.000552	0.000723	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—BCHE—breast cancer	0.000545	0.00294	CbGpPWpGaD
Tolazamide—Dizziness—Docetaxel—breast cancer	0.000533	0.000698	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—breast cancer	0.000532	0.000697	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000526	0.00284	CbGpPWpGaD
Tolazamide—Discomfort—Doxorubicin—breast cancer	0.000519	0.000679	CcSEcCtD
Tolazamide—Dizziness—Capecitabine—breast cancer	0.000516	0.000676	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—breast cancer	0.000511	0.00067	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	0.00051	0.00275	CbGpPWpGaD
Tolazamide—Rash—Docetaxel—breast cancer	0.000508	0.000666	CcSEcCtD
Tolazamide—Headache—Docetaxel—breast cancer	0.000505	0.000662	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—breast cancer	0.000502	0.000657	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—breast cancer	0.000501	0.000656	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	0.000495	0.00267	CbGpPWpGaD
Tolazamide—Thrombocytopenia—Doxorubicin—breast cancer	0.000493	0.000645	CcSEcCtD
Tolazamide—Rash—Capecitabine—breast cancer	0.000492	0.000645	CcSEcCtD
Tolazamide—Headache—Capecitabine—breast cancer	0.000489	0.000641	CcSEcCtD
Tolazamide—Nausea—Docetaxel—breast cancer	0.000479	0.000627	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—breast cancer	0.000479	0.000627	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—breast cancer	0.000479	0.000627	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—MDM2—breast cancer	0.00047	0.00254	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Epirubicin—breast cancer	0.000469	0.000615	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—breast cancer	0.000469	0.000614	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—RAF1—breast cancer	0.000469	0.00253	CbGpPWpGaD
Tolazamide—Nausea—Capecitabine—breast cancer	0.000464	0.000607	CcSEcCtD
Tolazamide—Urticaria—Methotrexate—breast cancer	0.000462	0.000605	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SYNJ2—breast cancer	0.000461	0.00249	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—COMT—breast cancer	0.000449	0.00242	CbGpPWpGaD
Tolazamide—Feeling abnormal—Epirubicin—breast cancer	0.000448	0.000587	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—SYNJ2—breast cancer	0.000447	0.00241	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000447	0.00241	CbGpPWpGaD
Tolazamide—Dyspepsia—Doxorubicin—breast cancer	0.000443	0.00058	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—COMT—breast cancer	0.000436	0.00235	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000434	0.000569	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—breast cancer	0.000434	0.000568	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—breast cancer	0.000432	0.000566	CcSEcCtD
Tolazamide—ABCC8—Metabolism—NDUFS3—breast cancer	0.000429	0.00231	CbGpPWpGaD
Tolazamide—Asthenia—Methotrexate—breast cancer	0.000417	0.000546	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—NDUFS3—breast cancer	0.000416	0.00224	CbGpPWpGaD
Tolazamide—Feeling abnormal—Doxorubicin—breast cancer	0.000415	0.000543	CcSEcCtD
Tolazamide—Pruritus—Methotrexate—breast cancer	0.000411	0.000539	CcSEcCtD
Tolazamide—ABCC8—Metabolism—CHST9—breast cancer	0.000403	0.00218	CbGpPWpGaD
Tolazamide—Urticaria—Doxorubicin—breast cancer	0.0004	0.000524	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—CHST9—breast cancer	0.000391	0.00211	CbGpPWpGaD
Tolazamide—Asthenia—Epirubicin—breast cancer	0.00039	0.000511	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—breast cancer	0.000385	0.000504	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—breast cancer	0.000384	0.000503	CcSEcCtD
Tolazamide—ABCC8—Metabolism—COX11—breast cancer	0.000382	0.00206	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000372	0.00201	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—COX11—breast cancer	0.000371	0.002	CbGpPWpGaD
Tolazamide—Rash—Methotrexate—breast cancer	0.000366	0.00048	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000365	0.00197	CbGpPWpGaD
Tolazamide—Headache—Methotrexate—breast cancer	0.000364	0.000477	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—breast cancer	0.000361	0.000473	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—breast cancer	0.00036	0.000471	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—breast cancer	0.000356	0.000466	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SHMT1—breast cancer	0.00035	0.00189	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CDA—breast cancer	0.00035	0.00189	CbGpPWpGaD
Tolazamide—Nausea—Methotrexate—breast cancer	0.000345	0.000452	CcSEcCtD
Tolazamide—Rash—Epirubicin—breast cancer	0.000343	0.000449	CcSEcCtD
Tolazamide—Headache—Epirubicin—breast cancer	0.000341	0.000446	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—CDA—breast cancer	0.000339	0.00183	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SHMT1—breast cancer	0.000339	0.00183	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A5—breast cancer	0.000337	0.00182	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLCO1B1—breast cancer	0.000337	0.00182	CbGpPWpGaD
Tolazamide—Dizziness—Doxorubicin—breast cancer	0.000333	0.000436	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—SLCO1B1—breast cancer	0.000326	0.00176	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A5—breast cancer	0.000326	0.00176	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—APRT—breast cancer	0.000325	0.00175	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—TFRC—breast cancer	0.000325	0.00175	CbGpPWpGaD
Tolazamide—Nausea—Epirubicin—breast cancer	0.000323	0.000423	CcSEcCtD
Tolazamide—Rash—Doxorubicin—breast cancer	0.000317	0.000416	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—APRT—breast cancer	0.000315	0.0017	CbGpPWpGaD
Tolazamide—Headache—Doxorubicin—breast cancer	0.000315	0.000413	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000313	0.00169	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ANGPTL4—breast cancer	0.000306	0.00165	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ESRRA—breast cancer	0.000306	0.00165	CbGpPWpGaD
Tolazamide—Nausea—Doxorubicin—breast cancer	0.000299	0.000392	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000298	0.00161	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ESRRA—breast cancer	0.000296	0.0016	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ANGPTL4—breast cancer	0.000296	0.0016	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPI—breast cancer	0.00029	0.00156	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HADHB—breast cancer	0.00029	0.00156	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000288	0.00155	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—BRAF—breast cancer	0.000287	0.00155	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPI—breast cancer	0.000281	0.00152	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HADHB—breast cancer	0.000281	0.00152	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—BRAF—breast cancer	0.000278	0.0015	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALDH1A1—breast cancer	0.000276	0.00149	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALDH7A1—breast cancer	0.000276	0.00149	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALDH7A1—breast cancer	0.000268	0.00145	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALDH1A1—breast cancer	0.000268	0.00145	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UMPS—breast cancer	0.000265	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—FHL2—breast cancer	0.000265	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NME1—breast cancer	0.000265	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ADSL—breast cancer	0.000265	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PHGDH—breast cancer	0.000265	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000264	0.00142	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LDHB—breast cancer	0.00026	0.0014	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—BRIP1—breast cancer	0.00026	0.0014	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HPSE—breast cancer	0.00026	0.0014	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—HRAS—breast cancer	0.000258	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UMPS—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NME1—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ADSL—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PHGDH—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—FHL2—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PLG—breast cancer	0.000257	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HPSE—breast cancer	0.000252	0.00136	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—BRIP1—breast cancer	0.000252	0.00136	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LDHB—breast cancer	0.000252	0.00136	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HMMR—breast cancer	0.000246	0.00133	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCC1—breast cancer	0.000246	0.00133	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA3—breast cancer	0.000246	0.00133	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—MDM2—breast cancer	0.00024	0.0013	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—RAF1—breast cancer	0.000239	0.00129	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HMMR—breast cancer	0.000239	0.00129	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCC1—breast cancer	0.000239	0.00129	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA3—breast cancer	0.000239	0.00129	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPARGC1B—breast cancer	0.000239	0.00129	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000237	0.00128	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—MDM2—breast cancer	0.000233	0.00126	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—RAF1—breast cancer	0.000232	0.00125	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPARGC1B—breast cancer	0.000231	0.00125	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000228	0.00123	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CA9—breast cancer	0.000225	0.00122	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA4—breast cancer	0.000225	0.00122	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPX2—breast cancer	0.00022	0.00118	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA2—breast cancer	0.00022	0.00118	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA4—breast cancer	0.000219	0.00118	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CA9—breast cancer	0.000219	0.00118	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPX4—breast cancer	0.000217	0.00117	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SULT1A1—breast cancer	0.000217	0.00117	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA2—breast cancer	0.000213	0.00115	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPX2—breast cancer	0.000213	0.00115	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—IDH1—breast cancer	0.000212	0.00114	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA1—breast cancer	0.000212	0.00114	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPX4—breast cancer	0.00021	0.00113	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SULT1A1—breast cancer	0.00021	0.00113	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NAT2—breast cancer	0.00021	0.00113	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—IDH1—breast cancer	0.000205	0.00111	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA1—breast cancer	0.000205	0.00111	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NAT2—breast cancer	0.000203	0.0011	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MED12—breast cancer	0.000184	0.000991	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—DPYD—breast cancer	0.000184	0.000991	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALDOA—breast cancer	0.000181	0.000975	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—DPYD—breast cancer	0.000178	0.000961	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MED12—breast cancer	0.000178	0.000961	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA3—breast cancer	0.000176	0.000947	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALDOA—breast cancer	0.000175	0.000946	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A2—breast cancer	0.000174	0.00094	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CPT1A—breast cancer	0.000171	0.000921	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTR—breast cancer	0.000171	0.000921	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCG2—breast cancer	0.000171	0.000921	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA3—breast cancer	0.00017	0.000918	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A2—breast cancer	0.000169	0.000912	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HPGDS—breast cancer	0.000167	0.000903	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HBA1—breast cancer	0.000166	0.000898	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCG2—breast cancer	0.000166	0.000893	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTR—breast cancer	0.000166	0.000893	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CPT1A—breast cancer	0.000166	0.000893	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ACHE—breast cancer	0.000162	0.000876	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTT1—breast cancer	0.000162	0.000876	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HPGDS—breast cancer	0.000162	0.000876	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HBA1—breast cancer	0.000161	0.00087	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ACHE—breast cancer	0.000158	0.00085	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTT1—breast cancer	0.000158	0.00085	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP17A1—breast cancer	0.000154	0.000829	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ENO1—breast cancer	0.000152	0.000821	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGS1—breast cancer	0.000152	0.000821	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2D6—breast cancer	0.000149	0.000805	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP17A1—breast cancer	0.000149	0.000804	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTGS1—breast cancer	0.000148	0.000796	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ENO1—breast cancer	0.000148	0.000796	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA2—breast cancer	0.000147	0.00079	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2D6—breast cancer	0.000145	0.000781	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ALB—breast cancer	0.000142	0.000768	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—FASN—breast cancer	0.000142	0.000766	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA2—breast cancer	0.000142	0.000766	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—BCHE—breast cancer	0.000142	0.000763	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC5A5—breast cancer	0.00014	0.000754	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—FASN—breast cancer	0.000138	0.000743	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—BCHE—breast cancer	0.000137	0.00074	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC5A5—breast cancer	0.000136	0.000731	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A1—breast cancer	0.000135	0.000728	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NQO1—breast cancer	0.000135	0.000728	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—HRAS—breast cancer	0.000132	0.000711	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP3A4—breast cancer	0.000132	0.00071	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A1—breast cancer	0.000131	0.000706	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NQO1—breast cancer	0.000131	0.000706	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1B1—breast cancer	0.000129	0.000698	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—RAF1—breast cancer	0.000129	0.000694	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—HRAS—breast cancer	0.000128	0.00069	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP3A4—breast cancer	0.000128	0.000689	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSP90AA1—breast cancer	0.000127	0.000685	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1B1—breast cancer	0.000126	0.000677	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA1—breast cancer	0.000123	0.000666	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSP90AA1—breast cancer	0.000123	0.000664	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—STK11—breast cancer	0.000122	0.000656	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP19A1—breast cancer	0.000122	0.000656	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA1—breast cancer	0.00012	0.000646	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP19A1—breast cancer	0.000118	0.000636	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—STK11—breast cancer	0.000118	0.000636	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—COMT—breast cancer	0.000113	0.00061	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTP1—breast cancer	0.000113	0.000607	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HMOX1—breast cancer	0.000111	0.000599	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ITPR1—breast cancer	0.000111	0.000598	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—COMT—breast cancer	0.00011	0.000592	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTP1—breast cancer	0.000109	0.000589	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HMOX1—breast cancer	0.000108	0.000581	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ITPR1—breast cancer	0.000107	0.000579	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCB1—breast cancer	0.000107	0.000575	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TYMS—breast cancer	0.000105	0.000565	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM1—breast cancer	0.000103	0.000558	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PLA2G4A—breast cancer	0.000103	0.000558	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOR1—breast cancer	0.000103	0.000558	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCB1—breast cancer	0.000103	0.000557	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TYMS—breast cancer	0.000102	0.000547	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PLA2G4A—breast cancer	0.0001	0.000541	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOR1—breast cancer	0.0001	0.000541	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM1—breast cancer	0.0001	0.000541	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPX1—breast cancer	9.91e-05	0.000534	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1A1—breast cancer	9.81e-05	0.000529	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ERCC2—breast cancer	9.73e-05	0.000525	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPX1—breast cancer	9.61e-05	0.000518	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1A1—breast cancer	9.51e-05	0.000513	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ERCC2—breast cancer	9.43e-05	0.000509	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTHFR—breast cancer	9.14e-05	0.000493	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTHFR—breast cancer	8.87e-05	0.000478	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CAV1—breast cancer	8.44e-05	0.000455	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CAV1—breast cancer	8.18e-05	0.000441	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CG—breast cancer	7.68e-05	0.000414	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CG—breast cancer	7.45e-05	0.000402	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CD—breast cancer	6.75e-05	0.000364	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALB—breast cancer	6.67e-05	0.00036	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CD—breast cancer	6.55e-05	0.000353	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALB—breast cancer	6.47e-05	0.000349	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NOS3—breast cancer	6.38e-05	0.000344	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NOS3—breast cancer	6.18e-05	0.000334	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CB—breast cancer	5.89e-05	0.000318	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGS2—breast cancer	5.83e-05	0.000315	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CB—breast cancer	5.71e-05	0.000308	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTGS2—breast cancer	5.66e-05	0.000305	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTEN—breast cancer	5.09e-05	0.000274	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTEN—breast cancer	4.93e-05	0.000266	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CA—breast cancer	3.59e-05	0.000194	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CA—breast cancer	3.48e-05	0.000188	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKT1—breast cancer	2.93e-05	0.000158	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKT1—breast cancer	2.84e-05	0.000153	CbGpPWpGaD
